Stock data
BioAge Labs, Inc. (BIOA)
BioAge Labs, Inc. (BIOA) reported revenue of US$8.99M and net income of -US$80.61M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$8.99M | — | -US$92.78M | -US$80.61M | — |
| 2024 | US$0.00M | — | -US$78.19M | -US$71.11M | — |
| 2023 | — | — | -US$48.40M | -US$63.85M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$2.45M | -US$26.10M | — |
| 2026-03-31 | US$2.77M | -US$22.25M | — |
| 2025-12-31 | US$3.08M | -US$25.94M | — |
| 2025-09-30 | US$2.05M | -US$20.17M | — |
| 2025-06-30 | US$2.41M | -US$21.56M | — |
| 2025-03-31 | US$1.45M | -US$12.93M | — |
| 2024-12-31 | — | -US$21.13M | — |
| 2024-09-30 | US$0.00M | -US$23.41M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.